Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia
Clinical trial NCT03214588 · COMPLETED
Trial details
- NCT number
- NCT03214588
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-08
- Primary completion
- 2018-12-27
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.